261 related articles for article (PubMed ID: 26196950)
1. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
[TBL] [Abstract][Full Text] [Related]
3. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cyclic Cushing's disease using late night salivary cortisol testing.
Jahandideh D; Swearingen B; Nachtigall LB; Klibanski A; Biller BMK; Tritos NA
Clin Endocrinol (Oxf); 2018 Sep; 89(3):336-345. PubMed ID: 29873834
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.
Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA
Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
7. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.
Findling JW; Fleseriu M; Newell-Price J; Petersenn S; Pivonello R; Kandra A; Pedroncelli AM; Biller BM
Endocrine; 2016 Nov; 54(2):516-523. PubMed ID: 27209465
[TBL] [Abstract][Full Text] [Related]
8. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
Carroll TB; Javorsky BR; Findling JW
Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
[TBL] [Abstract][Full Text] [Related]
9. Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population.
Aberle J; Schulze Zur Wiesch C; Flitsch J; Veigel J; Schön G; Jung R; Reining F; Lautenbach A; Rotermund R; Riedel N
J Endocrinol Invest; 2018 Nov; 41(11):1325-1331. PubMed ID: 29550934
[TBL] [Abstract][Full Text] [Related]
10. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
[TBL] [Abstract][Full Text] [Related]
12. Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.
Carrasco CA; Coste J; Guignat L; Groussin L; Dugué MA; Gaillard S; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Dec; 93(12):4728-34. PubMed ID: 18728161
[TBL] [Abstract][Full Text] [Related]
13. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
[TBL] [Abstract][Full Text] [Related]
14. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
[TBL] [Abstract][Full Text] [Related]
15. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
16. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER
J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
[TBL] [Abstract][Full Text] [Related]
17. Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up.
Valderrábano P; Aller J; García-Valdecasas L; García-Uría J; Martín L; Palacios N; Estrada J
Endocrinol Nutr; 2014 Apr; 61(4):176-83. PubMed ID: 24355549
[TBL] [Abstract][Full Text] [Related]
18. Late-night salivary cortisol as a screening test for Cushing's syndrome.
Raff H; Raff JL; Findling JW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
[TBL] [Abstract][Full Text] [Related]
19. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease.
Romanholi DJ; Machado MC; Pereira CC; Danilovic DS; Pereira MA; Cescato VA; Cunha Neto MB; Musolino NR; de Mendonça BB; Salgado LR
Clin Endocrinol (Oxf); 2008 Jul; 69(1):117-22. PubMed ID: 18182093
[TBL] [Abstract][Full Text] [Related]
20. The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing's Disease.
Vassiliadi DA; Balomenaki M; Asimakopoulou A; Botoula E; Tzanela M; Tsagarakis S
J Clin Endocrinol Metab; 2016 Dec; 101(12):4878-4885. PubMed ID: 27662440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
